Do you advise patents to use Ivermectin?
No I do not. Monoclonals are superior in everyday to Ivemecting, and the literature on ivermectin is not definitive. Therefore do not encourage the delay of excellent and proper care when time is of the essence for something that is simply not as good. The literature clearly demonstrate that monoclonal antibodies are the best therapeutic we have.